Importantly, the axis of mTORC2/acetylated FoxO/c-Myc expression confers an adverse prognostic impact to GBM patients, and it can be abrogated by dual PI3K/mTOR kinase inhibition, resulting in tumor cell death of xenograft tumor models using patient-derived GBM neurospheres. The gene discussed is MTOR; the disease is neoplasm.